Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | CTSG | P08311 | 1/20 | 0.43 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.43 |
| ▸ | CMA1 | P23946 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | F2R | P25116 | 1/20 | 0.41 |
| ▸ | CACNA1A | O00555 | 1/20 | 0.41 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.41 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6633302 | 0.90 | GAA (0.47) | GAALMNAHTTSMN1; SMN2ALDH1A1 | |
| SCHEMBL4595499 | 0.85 | ELANE (0.49) | PRSS1CTSGCTRB1CMA1GAA | |
| SCHEMBL4593922 | 0.82 | ELANE (0.45) | PRSS1CTSGCTRB1CMA1LMNA | |
| SCHEMBL11822391 | 0.79 | LMNA (0.50) | LMNAHTTSMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL4595692 | 0.78 | GAA (0.44) | GAALMNASMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL1792855 | 0.77 | MEN1 (0.47) | GAAMEN1KMT2ATNFRSF1AF2R | |
| SCHEMBL8827076 | 0.76 | CES2 (0.56) | GAALMNAHTTSMN1; SMN2ALDH1A1 | |
| Methane SCHEMBL28978438 | 0.76 | MEN1 (0.46) | GAAMEN1KMT2ATNFRSF1AF2R | |
| SCHEMBL31266976 | 0.75 | L3MBTL1 (0.61) | GAALMNAHTTSMN1; SMN2ALDH1A1 | |
| SCHEMBL4594767 | 0.75 | ALDH1A1 (0.43) | GAALMNAHTTSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1417209-B1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORP (US) | 2008-01-16 | — | — | EP | claimed |
| EP-1417209-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | Crompton Corporation (US) | 2004-05-12 | — | — | EP | claimed |
| US-20030065177-A1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION, A CORPORATION OF THE STATE OF DELAWARE | 2003-04-03 | — | — | US | claimed |
| WO-2003014130-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORPORATION (US) | 2003-02-20 | — | — | WO | claimed |
| US-6475347-B1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION | 2002-11-05 | — | — | US | claimed |
| EP-1417209-B1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORP (US) | 2008-01-16 | — | — | EP | disclosed |
| EP-1417209-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | Crompton Corporation (US) | 2004-05-12 | — | — | EP | disclosed |
| US-20030065177-A1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION, A CORPORATION OF THE STATE OF DELAWARE | 2003-04-03 | — | — | US | disclosed |
| WO-2003014130-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORPORATION (US) | 2003-02-20 | — | — | WO | disclosed |
| US-6475347-B1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION | 2002-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065177-A1 | High boiling inhibitors for distillable, polymerizable monomers | ROS1, POLR1A, ACP1 | PRSS1 2330/4885CTSG 4382/4885CTRB1 1403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.